DEA schedule
Is benralizumab a controlled substance?
Federal schedule for benralizumab from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Benralizumab is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and benralizumab is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted benralizumab?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 3 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | benralizumab is not on the list |
Benralizumab NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0310-1745 | FASENRA | injection, solution | 10 mg/.5mL | AstraZeneca Pharmaceuticals LP | None |
| 0310-1730 | FASENRA | injection, solution | 30 mg/mL | AstraZeneca Pharmaceuticals LP | None |
| 0310-1830 | FASENRA | injection, solution | 30 mg/mL | AstraZeneca Pharmaceuticals LP | None |
Questions
Is benralizumab a controlled substance?
No. Benralizumab is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and benralizumab is not on the DEA controlled substances list.
Is benralizumab a narcotic?
No. Benralizumab is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Interleukin-5 Receptor alpha-directed Cytolytic Antibody.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Benralizumab
- What is Benralizumab used for?FDA label uses
- Is Fasenra a controlled substance?Federal schedule
- Interleukin-5 Receptor alpha-directed Cytolytic Antibodies listFDA drug class
- Benralizumab Medicare Part D coverageBy plan and state
- NDC 0310-1730Benralizumab NDC record
- NDC 0310-1745Benralizumab NDC record
- NDC 0310-1830Benralizumab NDC record